FDA Approves Nerlynx to Help Prevent HER2 + Breast CA Return

Drug is a kinase inhibitor that works by blocking several enzymes that promote cell growth

Source: The Doctors Lounge - Oncology - July 19, 2017 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, Institutional, Source Type: news